Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway
Jing Wen(Zhejiang University of Finance and Economics), Yusen Zhou(Southeast University), Lanying Du(Georgia State University), Shibo Jiang(Shanghai Medical College of Fudan University), Yi Yang(First Hospital of Lanzhou University), Zhihua Kou(Institute of Microbiology), Hong Yu(Institute of Microbiology), Xia Jin(Anhui Medical University), Shuang Tong(First Hospital of China Medical University), Guangyu Zhao(Academy of Military Medical Sciences)
Cited by 43
Related Papers
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
|Cell Research|2020|1.4k
Dramatic Rise in Plasma Viremia after CD8+ T Cell Depletion in Simian Immunodeficiency Virus–infected Macaques
|The Journal of Experimental Medicine|1999|1.4k
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
|Frontiers in Microbiology|2020|442
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
|Nature Communications|2014|400